APA

Lichterfeld M., Gandhi R. T., Simmons R. P., Flynn T., Sbrolla A., Yu X. G., Basgoz N., Mui S., Williams K., Streeck H., Burgett-Yandow N., Roy G., Janssens M., Pedneault L., Vandepapelière P., Koutsoukos M., Demoitié M., Bourguignon P., McNally L., Voss G. & Altfeld M. (20120202). Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Lichterfeld Mathias, Gandhi Rajesh T, Simmons Rachel P, Flynn Theresa, Sbrolla Amy, Yu Xu G, Basgoz Nesli, Mui Stanley, Williams Katie, Streeck Hendrik, Burgett-Yandow Nicole, Roy Gilbert, Janssens Michel, Pedneault Louise, Vandepapelière Pierre, Koutsoukos Marguerite, Demoitié Marie-Ange, Bourguignon Patricia, McNally Lisa, Voss Gerald and Altfeld Marcus. 20120202. Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Lichterfeld M., Gandhi R. T., Simmons R. P., Flynn T., Sbrolla A., Yu X. G., Basgoz N., Mui S., Williams K., Streeck H., Burgett-Yandow N., Roy G., Janssens M., Pedneault L., Vandepapelière P., Koutsoukos M., Demoitié M., Bourguignon P., McNally L., Voss G. and Altfeld M. (20120202). Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals. : Journal of acquired immune deficiency syndromes (1999).

MLA

Lichterfeld Mathias, Gandhi Rajesh T, Simmons Rachel P, Flynn Theresa, Sbrolla Amy, Yu Xu G, Basgoz Nesli, Mui Stanley, Williams Katie, Streeck Hendrik, Burgett-Yandow Nicole, Roy Gilbert, Janssens Michel, Pedneault Louise, Vandepapelière Pierre, Koutsoukos Marguerite, Demoitié Marie-Ange, Bourguignon Patricia, McNally Lisa, Voss Gerald and Altfeld Marcus. Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals. : Journal of acquired immune deficiency syndromes (1999). 20120202.